Carbonyl compounds
eMolecules 51336-95-9 | 2-Chloro-1-(3,4-difluoro-phenyl)-ethanone | Combi-Blocks | MFCD03966888 | 190.570 | C8H5ClF2O | 98.000 | Fc1ccc(cc1F)C(=O)CCl | 5g | 205411071
2-Chloro-1-(3,4-difluoro-phenyl)-ethanone | Combi-Blocks | 51336-95-9 | MFCD03966888 | 190.570 | C8H5ClF2O | 98.000 | Fc1ccc(cc1F)C(=O)CCl | 5g | 205411071
Sigma Aldrich Fine Chemicals Biosciences Veratraldehyde >=98%, FG | 120-14-9 | MFCD00003363 | 10KG
Veratraldehyde >=98%, FG | Purity: >=98% | Mol Wt: 166.17 | 120-14-9 | MFCD00003363 | 10KG
Sigma Aldrich Fine Chemicals Biosciences Verapamil Related Compound E United States Pharmacopeia (USP) Reference Standard | 120-14-9 | MFCD00003363 | 50MG
Verapamil Related Compound E United States Pharmacopeia (USP) Reference Standard | Mol Wt: 166.17 | 120-14-9 | MFCD00003363 | 50MG
Sigma Aldrich Fine Chemicals Biosciences Veratraldehyde >=98%, FG | 120-14-9 | MFCD00003363 | 5KG
Veratraldehyde >=98%, FG | Purity: >=98% | Mol Wt: 166.17 | 120-14-9 | MFCD00003363 | 5KG
Sigma Aldrich Fine Chemicals Biosciences Veratraldehyde >=98%, FG | 120-14-9 | MFCD00003363 | 1KG
Veratraldehyde >=98%, FG | Purity: >=98% | Mol Wt: 166.17 | 120-14-9 | MFCD00003363 | 1KG
eMolecules 50901-34-3 | ChemScene | Antioxidant agent-4 | 100mg | 441668210 | CS-0069216 | 168.148 | C8H8O4
ChemScene | Antioxidant agent-4 | 100mg | 441668210 | CS-0069216 | 50901-34-3 | 168.148 | C8H8O4
Chem-Impex International, Inc. 4-Benzyloxybenzaldehyde | MFCD00003387 | 25G
4-Benzyloxybenzaldehyde, MFCD00003387, 25G
Sigma Aldrich Fine Chemicals Biosciences Amiodarone Related Compound E United States Pharmacopeia (USP) Reference Standard | 52490-15-0 | 25MG
Amiodarone Related Compound E United States Pharmacopeia (USP) Reference Standard | Mol Wt: 294.34 | 52490-15-0 | 25MG
eMolecules 712-09-4 | Medchem Express | 5-Methoxytryptophol | 25mg | 680109526 | HY-113440 | MFCD00047196 | 191.23 | C11H13NO2
Medchem Express | 5-Methoxytryptophol | 25mg | 680109526 | HY-113440 | 712-09-4 | MFCD00047196 | 191.230 | C11H13NO2
Medchemexpress LLC β-D-Glucopyranosyl abscisate | 21414-42-6 | 95.04% | 426.46 | 25 MG
β-D-Glucopyranosyl abscisate (ABA-GE) is a hydrolyzable abscisic acid (ABA) conjugate that accumulates in the vacuole and presumably also in the endoplasmic reticulum. Its deconjugation allows the rapid formation of free ABA in response to abiotic stress conditions like dehydration and salt stress. It also contributes to the maintenance of ABA homeostasis.
- Hydrolyzable abscisic acid (ABA) conjugate
- Accumulates in the vacuole and endoplasmic reticulum
- Deconjugation allows rapid formation of free ABA under abiotic stress
- Contributes to abscisic acid (ABA) homeostasis
Matrix Scientific 4 -NITRO 1,1 -BIPHENYL --500MG
4'-Nitro[1,1'-biphenyl]-4-carbaldehyde, >95%; 500mg,C13H9NO3, MFCD06200931, mw 227.22, [98648-23-8]
Matrix Scientific 2-FLUOROCYCLOHEXANONE-500MG
2-Fluorocyclohexanone, 500mg,C6H9FO, MFCD01076476, mw 116.14, [694-82-6]
Chem-Impex International, Inc. 4-Fluoro-2-methoxyacetophenone | MFCD00061143 | 5G
4-Fluoro-2-methoxyacetophenone, MFCD00061143, 5G
Medchemexpress LLC 4F 4PP oxalate | 144734-36-1 | 98.9% | 429.49 g/mol | C24H28FNO5 | 100 MG
4F 4PP oxalate is a research reagent that acts as a selective antagonist of the serotonin 5-HT2A receptor. It displays high affinity for 5-HT2A (Ki ≈ 5.3 nM) and substantially lower affinity for 5-HT2C (Ki ≈ 620 nM). Supplied as the oxalate salt, it is intended for in vitro and preclinical research use only.
- High affinity for 5-HT2A receptor (Ki ≈ 5.3 nM).
- Low affinity for 5-HT2C receptor (Ki ≈ 620 nM).
- Supplied as an oxalate salt for improved handling and stability.
- High purity suitable for research (≈98.9%).
- Available in small laboratory quantities (e.g., 5 mg-100 mg).
- Intended for in vitro and preclinical research use only.
Sigma Aldrich Fine Chemicals Biosciences Salicylaldehyde >=98%, FG | 90-02-8 | MFCD00003317 | 1KG
Salicylaldehyde >=98%, FG | Purity: >=98% | Mol Wt: 122.12 | 90-02-8 | MFCD00003317 | 1KG